Literature DB >> 35045753

Short Communication: S100A8 and S100A9, Biomarkers of SARS-CoV-2 Infection and Other Diseases, Suppress HIV Replication in Primary Macrophages.

Raphael M Oguariri1, Terrence W Brann1, Joseph W Adelsberger2, Qian Chen1, Suranjana Goswami1, Anthony R Mele1, Tomozumi Imamichi1.   

Abstract

S100A8 and S100A9 are members of the Alarmin family; these proteins are abundantly expressed in neutrophils, form a heterodimer complex, and are secreted in plasma on pathogen infection or acute inflammatory diseases. Recently, both proteins were identified as novel biomarkers of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and were shown to play key roles in inducing an aggressive inflammatory response by mediating the release of large amounts of pro-inflammatory cytokines, called the "cytokine storm." Although co-infection with SARS-CoV-2 in people living with HIV-1 may result in an immunocompromised status, the role of the S100A8/A9 complex in HIV-1 replication in primary T cells and macrophages is still unclear. Here, we evaluated the roles of the proteins in HIV replication to elucidate their functions. We found that the complex had no impact on virus replication in both cell types; however, the subunits of S100A8 and S100A9 inhibit HIV in macrophages. These findings provide important insights into the regulation of HIV viral loads during SARS-CoV-2 co-infection.

Entities:  

Keywords:  CD4+ T cells; S100A8; S100A9; monocyte-derived macrophages

Mesh:

Substances:

Year:  2022        PMID: 35045753      PMCID: PMC9131038          DOI: 10.1089/AID.2021.0193

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   1.723


  11 in total

Review 1.  S100A8 and S100A9 in inflammation and cancer.

Authors:  Christoffer Gebhardt; Julia Németh; Peter Angel; Jochen Hess
Journal:  Biochem Pharmacol       Date:  2006-07-17       Impact factor: 5.858

2.  Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock.

Authors:  Thomas Vogl; Klaus Tenbrock; Stephan Ludwig; Nadja Leukert; Christina Ehrhardt; Marieke A D van Zoelen; Wolfgang Nacken; Dirk Foell; Tom van der Poll; Clemens Sorg; Johannes Roth
Journal:  Nat Med       Date:  2007-09-02       Impact factor: 53.440

Review 3.  The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer.

Authors:  Jan M Ehrchen; Cord Sunderkötter; Dirk Foell; Thomas Vogl; Johannes Roth
Journal:  J Leukoc Biol       Date:  2009-05-18       Impact factor: 4.962

4.  HIV-1 transcription and virus production are both accentuated by the proinflammatory myeloid-related proteins in human CD4+ T lymphocytes.

Authors:  Carle Ryckman; Gilles A Robichaud; Jocelyn Roy; Réjean Cantin; Michel J Tremblay; Philippe A Tessier
Journal:  J Immunol       Date:  2002-09-15       Impact factor: 5.422

Review 5.  S100A8/A9 in Inflammation.

Authors:  Siwen Wang; Rui Song; Ziyi Wang; Zhaocheng Jing; Shaoxiong Wang; Jian Ma
Journal:  Front Immunol       Date:  2018-06-11       Impact factor: 7.561

6.  Induction of alarmin S100A8/A9 mediates activation of aberrant neutrophils in the pathogenesis of COVID-19.

Authors:  Qirui Guo; Yingchi Zhao; Junhong Li; Jiangning Liu; Xiuhong Yang; Xuefei Guo; Ming Kuang; Huawei Xia; Zeming Zhang; Lili Cao; Yujie Luo; Linlin Bao; Xiao Wang; Xuemei Wei; Wei Deng; Nan Wang; Luoying Chen; Jingxuan Chen; Hua Zhu; Ran Gao; Chuan Qin; Xiangxi Wang; Fuping You
Journal:  Cell Host Microbe       Date:  2020-12-26       Impact factor: 21.023

7.  Circulating Calprotectin as a Biomarker of COVID-19 Severity.

Authors:  Michael Mahler; Pier-Luigi Meroni; Maria Infantino; Katherine A Buhler; Marvin J Fritzler
Journal:  Expert Rev Clin Immunol       Date:  2021-04-13       Impact factor: 4.473

8.  IL-27 inhibits HIV-1 infection in human macrophages by down-regulating host factor SPTBN1 during monocyte to macrophage differentiation.

Authors:  Lue Dai; Kristy B Lidie; Qian Chen; Joseph W Adelsberger; Xin Zheng; DaWei Huang; Jun Yang; Richard A Lempicki; Tauseef Rehman; Robin L Dewar; Yanmei Wang; Ronald L Hornung; Kelsey A Canizales; Stephen J Lockett; H Clifford Lane; Tomozumi Imamichi
Journal:  J Exp Med       Date:  2013-03-04       Impact factor: 14.307

9.  Alarmin S100A9 restricts retroviral infection by limiting reverse transcription in human dendritic cells.

Authors:  Ghizlane Maarifi; Justine Lagisquet; Quentin Hertel; Boris Bonaventure; Célia Chamontin; Kyra Fuchs; Olivier Moncorgé; Marine Tauziet; Margaux Mombled; Laure Papin; Jean-Pierre Molès; Charles Bodet; Nicolas Lévèque; Antoine Gross; Nathalie Arhel; Sébastien Nisole; Philippe Van de Perre; Caroline Goujon; Fabien P Blanchet
Journal:  EMBO J       Date:  2021-06-14       Impact factor: 14.012

10.  Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19.

Authors:  Aymeric Silvin; Nicolas Chapuis; Garett Dunsmore; Anne-Gaëlle Goubet; Agathe Dubuisson; Lisa Derosa; Carole Almire; Clémence Hénon; Olivier Kosmider; Nathalie Droin; Philippe Rameau; Cyril Catelain; Alexia Alfaro; Charles Dussiau; Chloé Friedrich; Elise Sourdeau; Nathalie Marin; Tali-Anne Szwebel; Delphine Cantin; Luc Mouthon; Didier Borderie; Marc Deloger; Delphine Bredel; Severine Mouraud; Damien Drubay; Muriel Andrieu; Anne-Sophie Lhonneur; Véronique Saada; Annabelle Stoclin; Christophe Willekens; Fanny Pommeret; Frank Griscelli; Lai Guan Ng; Zheng Zhang; Pierre Bost; Ido Amit; Fabrice Barlesi; Aurélien Marabelle; Frédéric Pène; Bertrand Gachot; Fabrice André; Laurence Zitvogel; Florent Ginhoux; Michaela Fontenay; Eric Solary
Journal:  Cell       Date:  2020-08-05       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.